Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone for Sleep Disorders in Alzheimer's Disease
NCT01142258Phase 3Completed
- Sponsor
- Hospital Universitário de Brasília
- Start
- Mar 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sleep disorder comparing Trazodone with Placebo (2 arms). Primary endpoint: Change from Baseline in Nighttime Total Sleep Time at 14 days. Started Mar 2010; status: completed.
02
Drugs
trazodone
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT01142258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142258.